BACKGROUND: This article summarizes the varying clinical manifestations of three siblings with familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) caused by the same genetic lesion. METHODS: The medical records of three siblings with FHHNC (one girl and two boys, aged 6 to 12 years) were reviewed and the clinical manifestations and treatment of their disease were described. RESULTS: Despite varying phenotypes, each sibling had the same genetic lesion-a novel homozygous mutation in CLDN16 (c.211A>G, M71V). CONCLUSION: Although FHHNC is a rare disorder, this report is significant for the following reasons: (i) it describes a novel CLDN16 mutation causing FHHNC, adding to the literature of FHHNC-causing CLDN16 mutations; (ii) it suggests that genes other than CLDN16 or epigenetic factors are involved in the clinical spectrum of FHHNC; and (iii) it reinforces the variability of disease manifestation and genotype-phenotype correlations.
BACKGROUND: This article summarizes the varying clinical manifestations of three siblings with familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) caused by the same genetic lesion. METHODS: The medical records of three siblings with FHHNC (one girl and two boys, aged 6 to 12 years) were reviewed and the clinical manifestations and treatment of their disease were described. RESULTS: Despite varying phenotypes, each sibling had the same genetic lesion-a novel homozygous mutation in CLDN16 (c.211A>G, M71V). CONCLUSION: Although FHHNC is a rare disorder, this report is significant for the following reasons: (i) it describes a novel CLDN16 mutation causing FHHNC, adding to the literature of FHHNC-causing CLDN16 mutations; (ii) it suggests that genes other than CLDN16 or epigenetic factors are involved in the clinical spectrum of FHHNC; and (iii) it reinforces the variability of disease manifestation and genotype-phenotype correlations.
Authors: V Benigno; C S Canonica; A Bettinelli; R O von Vigier; A C Truttmann; M G Bianchetti Journal: Nephrol Dial Transplant Date: 2000-05 Impact factor: 5.992
Authors: Martin Konrad; Andre Schaller; Dominik Seelow; Amit V Pandey; Siegfried Waldegger; Annegret Lesslauer; Helga Vitzthum; Yoshiro Suzuki; John M Luk; Christian Becker; Karl P Schlingmann; Marcel Schmid; Juan Rodriguez-Soriano; Gema Ariceta; Francisco Cano; Ricardo Enriquez; Harald Juppner; Sevcan A Bakkaloglu; Matthias A Hediger; Sabina Gallati; Stephan C F Neuhauss; Peter Nurnberg; Stefanie Weber Journal: Am J Hum Genet Date: 2006-09-19 Impact factor: 11.025
Authors: Stefanie Weber; Linda Schneider; Melanie Peters; Joachim Misselwitz; Gabriele Rönnefarth; Michael Böswald; Klaus E Bonzel; Tomas Seeman; Tereza Suláková; Eberhard Kuwertz-Bröking; Alojz Gregoric; Jean-Bernard Palcoux; Velibor Tasic; Friedrich Manz; Karl Schärer; Hannsjörg W Seyberth; Martin Konrad Journal: J Am Soc Nephrol Date: 2001-09 Impact factor: 10.121
Authors: Martin Konrad; Jianghui Hou; Stefanie Weber; Jörg Dötsch; Jameela A Kari; Tomas Seeman; Eberhard Kuwertz-Bröking; Amira Peco-Antic; Velibor Tasic; Katalin Dittrich; Hammad O Alshaya; Rodo O von Vigier; Sabina Gallati; Daniel A Goodenough; André Schaller Journal: J Am Soc Nephrol Date: 2007-11-14 Impact factor: 10.121
Authors: P Jaya Kausalya; Salah Amasheh; Dorothee Günzel; Henrik Wurps; Dominik Müller; Michael Fromm; Walter Hunziker Journal: J Clin Invest Date: 2006-03-09 Impact factor: 14.808
Authors: Jianghui Hou; Aparna Renigunta; Martin Konrad; Antonio S Gomes; Eveline E Schneeberger; David L Paul; Siegfried Waldegger; Daniel A Goodenough Journal: J Clin Invest Date: 2008-02 Impact factor: 14.808
Authors: Hanuma K Karnati; Manas Panigrahi; Noor A Shaik; Nigel H Greig; S Appala R Bagadi; Mohammad A Kamal; Nagaiah Kapalavayi Journal: CNS Neurol Disord Drug Targets Date: 2014 Impact factor: 4.388
Authors: Paulo Marcio Yamaguti; Pollyanna Almeida Costa dos Santos; Bruno Sakamoto Leal; Viviane Brandão Bandeira de Mello Santana; Juliana Forte Mazzeu; Ana Carolina Acevedo; Francisco de Assis Rocha Neves Journal: BMC Nephrol Date: 2015-07-02 Impact factor: 2.388